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In humans, DOCK8 immunode!ciency syndrome is characterized by severe cutaneous viral 
infections. Thus, CD8 T cell function may be compromised in the absence of DOCK8. In  
this study, by analyzing mutant mice and humans, we demonstrate a critical, intrinsic role  
for DOCK8 in peripheral CD8 T cell survival and function. DOCK8 mutation selectively 
diminished the abundance of circulating naive CD8 T cells in both species, and in  
DOCK8-de!cient humans, most CD8 T cells displayed an exhausted CD45RA+CCR7  pheno-
type. Analyses in mice revealed the CD8 T cell abnormalities to be cell autonomous and 
primarily postthymic. DOCK8 mutant naive CD8 T cells had a shorter lifespan and, upon 
encounter with antigen on dendritic cells, exhibited poor LFA-1 synaptic polarization and a 
delay in the !rst cell division. Although DOCK8 mutant T cells underwent near-normal 
primary clonal expansion after primary infection with recombinant in"uenza virus in vivo, 
they showed greatly reduced memory cell persistence and recall. These !ndings highlight  
a key role for DOCK8 in the survival and function of human and mouse CD8 T cells.
© 2011 Randall et al. This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the !rst six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial– 
Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
CD8 T cells have a remarkable capacity for 
clonal expansion and play an important role in 
immunity (Masopust et al., 2007). Their essential 
role in immunity has been demonstrated in 
mice by genetic or antibody-mediated ablation 
studies (Doherty, 1996; Harty et al., 2000) and 
is evidenced in humans by chronic sinopulmo-
nary infections in rare individuals with selective 
CD8 T cell de!ciency caused by homozygous 
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range (Engelhardt et al., 2009; Zhang et al., 2009). In vitro 
stimulation with antibodies to CD3 and CD28 found that 
CD8 T cells from patients exhibited little or no proliferation 
compared with healthy controls, whereas CD4 T cell re-
sponses were diminished in some patients but relatively nor-
mal in others (Engelhardt et al., 2009; Zhang et al., 2009). 
However, it is unclear to what extent these e"ects are pri-
mary consequences of DOCK8 de!ciency in CD8 T cells or 
secondary to the multiple, recurrent infections a#icting 
DOCK8-de!cient patients or their treatment. For example, 
responses have yet to be measured in CD8 T cells fraction-
ated with respect to the various naive and memory subsets. 
The concurrent discovery of Dock8 mutant mice provides an 
opportunity to compare the consequences of DOCK8 de!-
ciency in T cells from both species, taking advantage of spe-
ci!c pathogen-free conditions and cell mixing experiments 
in mice to exclude confounding factors of humoral immuno-
de!ciency and concurrent infections.
In this study, we show that DOCK8 acts cell autono-
mously in CD8 T cells and that its de!ciency causes pro-
found qualitative abnormalities in mice and humans. In 
humans, the most striking e"ect is depletion of circulating 
naive CD8 T cells and accumulation of an exhausted subset 
of CD8 T cells that are unresponsive to CD3/CD28 stimula-
tion. In mice, the most striking e"ect is a failure of memory 
CD8 T cells to persist and mount a recall response after the 
!rst wave of CD8 T cell proliferation after in$uenza infec-
tion. The selective failure of memory CD8 T cell persistence 
parallels the e"ects of other mutations that a"ect LFA-1 or 
TCR concentration at the T cell synapse during initial anti-
gen encounter, and those parallels are borne out here by 
demonstrating that DOCK8 de!ciency diminishes recruit-
ment of LFA-1 to the CD8 T cell synapse with DCs. These 
results extend and translate to human immunity evidence for 
an intimate relationship between the quality of the CD8 
T cell immune synapse and the generation of long-lived, re-
callable memory CD8 T cells.
RESULTS
Altered differentiation and impaired proliferation of T cells 
from DOCK8-de!cient humans
To explore the e"ects of DOCK8 de!ciency on T cells, we 
!rst analyzed peripheral blood T cells from six DOCK8- 
de!cient patients from !ve unrelated kindreds. Some of the 
clinical characteristics of these patients are detailed in Table I. 
Consistent with a previous study (Engelhardt et al., 2009), 
the frequency of CD8 T cells within the total lymphocyte 
population from DOCK8-de!cient patients was comparable 
with that of normal age-matched controls (Fig. 1, A and B). 
However, when subsets of CD8 T cells were enumerated, 
there was a dramatic and highly signi!cant loss of naive 
(CD45RA+CCR7+) cells ( 10% in patients compared with 
45% in normal controls), together with a smaller but still 
signi!cant decrease in memory (CD45RA CCR7 /+) CD8 
T cells. Strikingly, the majority of CD8 T cells from DOCK8-
de!cient patients exhibited a CD45RA+CCR7  phenotype 
mutations in CD8, TAP1, or TAP2 (de la Salle et al., 1999; 
Gadola et al., 2000; de la Calle-Martin et al., 2001) or by the 
reconstitution of immunity to EBV and CMV with CD8 
T cells during transplantation (Walter et al., 1995). A key 
question in the !eld is how CD8 T cell di"erentiation into 
short-lived cytotoxic e"ector T cells is balanced against main-
taining a persisting pool of CD8 memory T cells with potent 
recall responses to avoid exhausting the pool of responding 
T cells and how failure of this process may contribute to 
chronic viral illness (Intlekofer et al., 2006; Williams et al., 
2006a; Sallusto et al., 2010). Answers to this question hold 
the potential for new interventions to promote long-lived 
CD8 T cell immunity in vaccination or chronic infection but 
require experimental studies that bridge human and mouse 
memory CD8 T cells.
The recent discovery of an immunode!ciency syndrome 
caused by inactivating mutations in DOCK8 in humans and 
mice (Engelhardt et al., 2009; Randall et al., 2009; Zhang 
et al., 2009) provides a unique opportunity to analyze the 
consequences of this speci!c molecular perturbation for 
CD8 T cells in both species. DOCK8 is a member of the 
DOCK family of intracellular signaling proteins, which are 
recruited to PIP3 (phosphatidylinositol-trisphosphate)-rich 
membranes through their DHR1 (Dock homology region 1) 
domain and serve as guanine exchange factors for Rho/
Rac family GTPases through their DHR2 domain (Côté 
and Vuori, 2007). Other members of this protein family are 
involved in polarized accumulation of cell adhesion mole-
cules and actin !laments required for cell adhesion, migra-
tion, and signaling events (Côté and Vuori, 2007). DOCK8 
is most highly expressed in B and T lymphocytes. Individuals 
with homozygous inactivating DOCK8 mutations present 
with clinical signs of combined B and T cell immunode!-
ciency: recurrent sinopulmonary infections typical of humoral 
immunode!ciency and severe cutaneous viral infections with 
HSV, human papillomavirus (HPV), and scarring Molluscum 
contagiosum suggestive of T cell dysfunction (Engelhardt et al., 
2009; Zhang et al., 2009). These patients also have severe 
atopy with almost universal atopic dermatitis and sensitization 
to both foods and aeroallergens. It is likely that DOCK8 
mutations account for most of the patients previously classi-
!ed as having autosomal recessive hyper-IgE syndrome 
(HIES [AR-HIES]; Engelhardt et al., 2009). Analysis of 
DOCK8-de!cient mice has shown that mutations in this 
gene cause a partial humoral immunode!ciency, a"ecting 
B cells autonomously to prevent long-lasting serum antibody 
production after immunization. DOCK8-de!cient B cells 
lack normal recruitment of ICAM-1 to the B cell immune 
synapse, are unable to form marginal zone B cells, and have 
greatly reduced persistence and a%nity maturation of germi-
nal center B cells (Randall et al., 2009).
In contrast, little is known about the e"ects of DOCK8 
de!ciency within the T cell lineage in humans or mice. 
Moderate decreases in circulating T cell numbers have been 
found in some human DOCK8-de!cient patients, although 
in many others the CD8 T cell count was within the normal 
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T cell compartment toward exhausted TEMRA cells in 
DOCK8 de!ciency reveals a separate e"ect that compli-
cates interpretation of the role of DOCK8 in human CD8 
T cell proliferation.
In contrast to the striking shift in CD8 T cell phenotypic 
subsets, when the CD4 T cell compartment of DOCK8-
de!cient patients was examined, although there was a signi!-
cant reduction in the frequency of CD4 T cells within the 
lymphocyte population, we found that the distribution of 
naive (CD45RA+CCR7+) and memory (CD45RA CCR7 /+) 
subsets in DOCK8-de!cient patients resembled that ob-
served for normal controls (Fig. 1, D and E). Despite this, 
functional analysis of naive and memory CD4 T cells from 
patients 1 (Fig. 1 F) and 2 (Fig. 1 G) revealed markedly di-
minished proliferation after stimulation with TAE beads 
compared with the vigorous division of corresponding CD4 
T cell subsets from normal donors. Furthermore, although 
division of the mutant DOCK8 T cells could be improved by 
exogenous IL-2, it remained substantially less than that of 
control cells (Fig. 1, F and G). Thus, DOCK8 de!ciency 
in humans diminishes clonal expansion of both CD4 and 
CD8 T cells in response to engagement of TCR and co-
stimulatory molecules.
CD8+ T cells in DOCK8-de!cient patients have undergone 
chronic activation in vivo
TEMRA cells have been found to have experienced exten-
sive replication in vivo (Hamann et al., 1999; Dunne et al., 
2002; Rufer et al., 2003) yet exhibit poor proliferation 
in vitro (Champagne et al., 2001; Geginat et al., 2003). 
(Fig. 1, A and B), which is typically associated with cell ex-
haustion or replicative senescence (Appay et al., 2008). Be-
cause of their reexpression of CD45RA, these cells have 
been termed e"ector memory CD45RA+ (TEMRA) cells.
For functional analyses, CD8 T cells from the di"erent pa-
tients were sorted into populations of either naive (CD45RA+ 
CCR7+), memory (CD45RA CCR7 /+), or TEMRA (CD45RA+ 
CCR7 ) cells, labeled with CFSE, and stimulated with T cell 
activation and expansion (TAE) beads, which were coated 
with mAb to human CD3, CD28, and CD2, in the absence 
or presence of IL-2. Because of the lymphopenia that is charac-
teristic of DOCK8-de!cient patients (Zhang et al., 2009), 
not all subsets of these cells could be recovered in su%cient 
numbers from all patients. Consequently, the data presented 
in Fig. 1 C are a composite derived from experiments per-
formed using subsets of CD8 T cells isolated from di"erent 
patients. Naive (CD45RA+CCR7+) and memory (CD45RA  
CCR7 /+) CD8 T cells from normal controls were induced 
to undergo multiple rounds of division in response to stimu-
lation with TAE beads, whereas the corresponding subset 
from DOCK8-de!cient patients failed to divide under these 
stimulatory conditions (Fig. 1 C). Notably, provision of ex-
ogenous IL-2 failed to improve proliferation of DOCK8-
de!cient memory cells (Fig. 1 C). In contrast, there was an 
absence of a proliferative response by TEMRA cells from either 
normal donors or patients (Fig. 1 C). This is consistent with 
previous !ndings that have investigated the CD8 TEMRA cell 
subset from normal donors as well as in other clinical settings 
(Champagne et al., 2001; Brenchley et al., 2003; Geginat 
et al., 2003; Papagno et al., 2004). The shift of the CD8 
Table I. DOCK8-de!cient patients
DOCK8-de!cient 
patients
Age at analysis DOCK8 mutation Effect on protein Clinical features
yr
#1 14 Homozygous 114-kb deletion 
spanning exons 4–26
Not expressed Pneumonia, eczema, cutaneous lesions, 
fungal infections, eosinophilia;  
IgE 4,800–10,000 IU/ml
#2 (patient ARH012; 
Engelhardt et al., 
2009)
12 Homozygous A→T mutation 
position 70 in exon 7
Premature stop codon: 
K271X
Severe M. contagiosum, pneumonia, 
meningitis, eczema; IgE 10,000 IU/ml
#3 4 Homozygous 150-kb deletion Not expressed M. contagiosum infection (family history)
#4 10 Large homozygous deletion Not expressed Recurrent otitis media, eczema, HPV, 
onychomycosis, Salmonella;  
IgE 1,552 IU/ml; suggestive in!ammatory 
bowel disease and vasculitis
#5 11 Large homozygous deletion Not expressed Recurrent upper respiratory tract infection, 
HPV, Giardia lamblia, Salmonella;  
IgE 19,302 IU/ml; in!ammatory bowel 
disease and vasculitis
#6 12 c.3733_3734delAG Premature stop codon: 
p.R1245EfsX5
Eczema (with methicillin-resistant S. aureus 
infection), M. contagiosum, recurrent otitis 
media (methicillin-resistant S. aureus), 
multiple food allergies; IgE 1,500 IU/ml
Patients #4 and #5 are siblings.
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not only acquire expression of CD57, but also dramatically 
up-regulate CD244 (2B4), CD11a, CD11b, CX3CR1, CD95, 
and granzyme B and concomitantly down-regulate CD27, 
CD28, and CD127 (IL-7R ; Fig. 2 and Fig. S1). Notably, 
expression of these molecules is substantially increased (CD244, 
CD11a, CD11b, CD57, CX3CR1, CD95, and granzyme B) 
or decreased (CD27, CD28, and CD127) on normal TEMRA 
cells (Fig. 2 and Fig. S1). Remarkably, the levels of ex-
pression of these molecules on memory CD8 T cells from 
DOCK8-de!cient patients resembled that of TEMRA cells 
from normal individuals (Fig. 2 and Fig. S1). Indeed, unlike 
normal memory and TEMRA cells, there was no signi!cant 
di"erence in their levels of expression between DOCK8-
de!cient memory CD8 T cells and normal TEMRA cells (Fig. 2 
and Fig. S1). Furthermore, these molecules were up- or 
Furthermore, in the setting of chronic viral infection, these 
cells may have undergone replicative senescence (Chen et al., 
2001; Brenchley et al., 2003; Papagno et al., 2004; Plunkett 
et al., 2005). A feature of the TEMRA cell population is expres-
sion of CD57 on a substantial proportion of these cells 
(Appay et al., 2008). Interestingly, CD57 expression corre-
lates with both an inability to undergo proliferation in re-
sponse to either polyclonal or antigen-speci!c stimulation 
and heightened susceptibility to apoptosis in vitro (Brenchley 
et al., 2003). To further analyze CD8 T cell subsets in 
DOCK8 de!ciency and to understand the proliferative de-
fects in these cells, we assessed expression of a range of mole-
cules whose expression is altered during di"erentiation of 
naive cells into e"ector cells (Appay et al., 2008). Compared 
with naive cells, memory CD8 T cells from normal donors 
Figure 1. DOCK8 de!ciency severely perturbs differentiation and proliferation of naive and memory human T cells. PBMCs from normal  
donors or DOCK8-de!cient patients were analyzed. (A and B) Representative FACS plots and quantitation of total CD8 T cells and naive (CD45RA+CCR7+), 
memory (CD45RA CCR7 ), and TEMRA (effector memory CD45+ [CD45RA+CCR7 ]) cell subsets. The FACS plots in A show one representative normal donor 
and one DOCK8-de!cient patient, whereas the graphs in B show data for all samples analyzed, with the horizontal bars representing the mean frequency 
of cells with the indicated phenotype. (C) CD8 naive, memory, and TEMRA T cells were isolated from normal donors and patients 1 and 2 (red histograms), 
labeled with CFSE, and then stimulated with TAE beads in the absence or presence of exogenous IL-2. Cell division was determined after 5 d by measuring 
dilution of CFSE. (D and E) Representative FACS plots and quantitation of total CD4 T cells and naive (CD45RA+CCR7+), memory (CD45RA CCR7 ), and 
TEMRA (CD45RA+CCR7 ) cell subsets. The FACS plots in D show one normal donor and one DOCK8-de!cient patient, whereas the graphs in E show data for 
all samples analyzed, with the horizontal bars representing the mean frequency of cells with the indicated phenotype. (F and G) CD4+ naive (left) and 
memory (right) T cells were isolated from normal donors and patients 1 (F) and 2 (G; red histograms), labeled with CFSE, and then stimulated with TAE 
beads in the absence of presence of exogenous IL-2. Cell division was determined after 5 d by measuring dilution of CFSE. Signi!cant differences were 
determined by the Student’s t test.
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CD8 T cells have undergone aberrant di"erentiation in vivo, 
such that most non-naive cells have acquired an e"ector/ 
exhausted phenotype, whereas naive cells exhibit features 
of early activation.
Intrinsic effects of DOCK8 de!ciency on circulating  
naive CD8 T cells
The cell-autonomous role of DOCK8 in T cells was further 
investigated in speci!c pathogen-free C57BL/6 mice homo-
zygous for the inactivating Dock8pri/pri mutation. These ani-
mals inherit a Ser>Pro substitution predicted to disrupt a key 
-helix in the Rho/Rac-binding site of the DHR2 domain and 
have a comparable phenotype with Dock8cpm/cpm 
mice homozygous for a truncating mutation 
that abolishes over half of the protein (Randall 
et al., 2009). We !rst sought to understand 
the depletion of naive CD8 T cells in human 
DOCK8 de!ciency by focusing on the forma-
tion and numbers of circulating naive CD8 
T cells in Dock8pri/pri mice.
Paralleling the human phenotype, the 
number of circulating naive CD8 T cells was 
decreased in Dock8pri/pri homozygous mutants 
(Fig. 3, A and B). CD8 and CD4 T cell subsets 
were subdivided into naive and activated/
memory cells by $ow cytometric staining for 
CD44. Naive CD44lo T cell subsets within 
both CD8 and CD4 populations were de-
creased 50% in blood, spleen, and LNs of 
Dock8pri/pri mice (Fig. 3, A and B; and Fig. S2). 
In contrast, the percentages and numbers of 
activated/memory CD44hi CD8 and CD4 
T cells were comparable or slightly increased in 
DOCK8 mutant animals. Further analysis of 
the expression of CD45RB, PD-1, CTLA-4, 
KLRG1, CD127, CD122, CD25, CD27, CD3, 
or Tbet on the CD8+CD44hi subset revealed no 
di"erence in Dock8pri/pri mice compared with 
normal controls (Fig. S3). Parallel analyses of 
Dock8cpm/cpm mice yielded comparable results 
(Figs. S3 and S4). These data indicate that 
DOCK8 de!ciency in speci!c pathogen-free 
mice also diminishes naive CD8 cells, but in 
down-regulated to a greater extent on DOCK8-de!cient 
TEMRA CD8 T cells compared with corresponding cells from 
normal donors (Fig. 2 and Fig. S1). Thus, the vast majority 
(>70%) of DOCK8-de!cient TEMRA CD8 T cells exhibited 
a CD57+CX3CR1+CD27 CD28 CD127  phenotype, com-
pared with only 40–50% of normal TEMRA cells which had 
this phenotype (Fig. 2). Remarkably, even naive CD8 T cells 
from DOCK8-de!cient patients di"ered phenotypically 
from normal naive cells inasmuch that they expressed ele-
vated levels of CD11a, CD11b, and CD95 and displayed a mild 
down-regulation of CD28, CD27, and CD127 (Fig. 2 and 
Fig. S1). Overall, these data suggest that DOCK8-de!cient 
Figure 2. Phenotypic analysis of human DOCK8-
de!cient CD8+ T cells. (A–E) PBMCs from normal  
donors (n = 9) or DOCK8-de!cient patients (n = 4) were 
labeled with anti-CD8, anti-CD45RA, and anti-CCR7 
mAbs and either isotype control or mAb speci!c for 
CD28, CD57, CD95, CD127 (IL-7Ra), and CX3CR1. The 
expression of these molecules on naive (CD45RA+CCR7+), 
memory (CD45RA CCR7 ), and TEMRA (CD45RA+CCR7 ) 
cell subsets of CD8 T cells was then determined. The  
histogram plots are from one representative normal donor 
or control. Each value in the graphs corresponds to an 
individual normal donor or patient; the horizontal bars 
represent the mean.
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observed in animals with defective thymic egress (Matloubian 
et al., 2004; Carlson et al., 2006; Shiow et al., 2008). More-
over, when the Dock8pri/pri mutation was crossed into trans-
genic mice expressing an MHC I–restricted TCR, OT-I, 
it caused no discernable decrease in the positive selection 
of CD8 single-positive T cells bearing this TCR (Fig. 3, 
E and F). Interestingly, the frequency of naive peripheral 
CD8 T cells bearing the OT-I TCR was una"ected by the 
Dock8pri/pri mutation. Collectively, these results indicate that 
DOCK8 de!ciency causes only subtle changes in thymic 
T cell di"erentiation.
The decrease in naive peripheral CD8 and CD4 T cells 
could re$ect either a cell-autonomous requirement of 
DOCK8 in these T cell subsets or a secondary e"ect of ab-
normalities in other cell types. To distinguish between these 
alternatives, we constructed mixed bone marrow chimeras by 
reconstituting irradiated mice with 50:50 mixtures of con-
genically marked bone marrow from Dock8pri/pri CD45.2 and 
Dock8+/+ CD45.1 donors. Peripheral B220+ cells were re-
constituted in almost equal ratios by mutant and WT cells, con-
sistent with previous results demonstrating no e"ect of the 
mutation on circulating B cell numbers (Randall et al., 2009) 
and thereby providing an internal measure for relative en-
graftment by the two marrow sources in each chimeric animal 
(reconstitution of individuals shown by bars in Fig. 4 A). In 
contrast, CD45.2+ T cells with defective DOCK8 were dra-
matically underrepresented in peripheral CD8 and CD4 
T cell subsets so that they comprised only 5% of circulating 
T cells on average. In the same animals, DOCK8 mutant T cells 
averaged 16% of thymic CD4 and CD8 single-positive 
T cells, 22% of CD4+CD8+ double-positive cells, and 30% 
of CD4 CD8  double-negative cells. The proportion of 
peripheral CD45.2+ CD8 T cells that were CD44hi in the 
mixed chimeras was not elevated, comprising 20% of 
Dock8pri/pri CD8 cells and 18% of Dock8+/+ CD8 cells (Fig. 4 B). 
Collectively, these results indicate that DOCK8 de!ciency 
has a subtle cell-autonomous e"ect on T cells that is com-
pounded at progressive stages of thymic and peripheral 
T cell formation.
To investigate further the decreased number of naive 
peripheral CD8 T cells, we adoptively transferred mixtures of 
congenically marked normal and Dock8pri/pri mutant spleen 
T cells into normal C57BL/6 mice. The survival of these 
adoptively transferred T cells was then determined by assess-
ing the total number of adoptively transferred cells present as 
well as the ratio of WT to mutant donor-derived T cells at 
various time points compared with their ratios at the time of 
injection. Both WT and mutant T cells slowly declined in 
frequency up to 39 d after adoptive transfer (Fig. 5, A and B). 
The contribution of mutant T cells as a percentage of total 
donor T cells was consistently lower than the input percent-
age. Similar results were obtained when the transferred WT 
and Dock8pri/pri T cells were obtained from OT-I TCR trans-
genic mice with a homogeneous TCR speci!city: mutant 
OT-I T cells accounted for 39% of the OT-I cells at the time 
of transfer but only 20% after 39 d, representing a halving of 
this situation it does not result in accumulation of exhausted 
memory CD8 T cells.
Decreased naive CD8 or CD4 T cells in the periphery of 
Dock8pri/pri mice was not explained by any consistent decrease 
in the numbers of CD8 or CD4 single-positive T cells in the 
thymus (Fig. 3 C). In some experiments, there were slightly 
fewer CD4 and CD8 T cells in the thymus of Dock8pri/pri mice 
(Fig. S5 A), although this was not consistently observed. 
Further subsetting of mature CD4 and CD8 thymocytes 
based on expression of CD62L and CD69 revealed slightly 
decreased frequencies of less mature CD69hiCD4+ and 
CD69hiCD8+ cells in Dock8pri/pri thymi as a percentage of the 
total lymphocytes (Fig. 3 D). There was no consistent evidence 
for accumulation or de!ciency of mature CD62L+CD69  
single-positive cells (Fig. 3 D and Fig. S5) in the thymus as is 
Figure 3. Analysis of T cells in Dock8pri/pri mice. (A) Representative 
"ow cytometry plots of T cells in the spleen of Dock8pri/pri and C57BL/6 
(+/+) mice. (B–D) Quantitation of T cells in spleen (B) and various subsets 
of thymic T cells (C and D) for age-matched C57BL/6 and Dock8pri/pri mice. 
Bars are means, error bars indicate SEM, and dots indicate individual mice. 
Statistical analysis was performed by the unpaired Student’s t test with 
Welch’s correction. Data are representative of three independent experi-
ments. (E) Representative "ow cytometry plots of thymic (top) and splenic 
(bottom) cells from OT-I mice. (F) Quantitation of thymic and splenic CD8 
T cells in WT and mutant OT-I mice. Bars are medians, and dots indicate 
individual mice.
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between the mutant and WT cells. Addition of 
exogenous IL-2 did not rectify the delayed !rst 
division of DOCK8 mutant T cells (not de-
picted). In vitro activated Dock8pri/pri CD8 
OT-I cells had normal cytotoxic activity in 
chromium release assays (Fig. S8), and normal 
TNF, IFN- , and IL-2 were produced by 
Dock8pri/pri CD8 cells in response to PMA and 
ionomycin (not depicted). DOCK8-de!cient nontransgenic 
T cells divided almost normally in response to anti-CD3 and 
CD28 antibodies, although there was again evidence of a 
slight decrease (not depicted).
To investigate earlier steps in CD8 T cell activation, 
DOCK8 mutant and WT naive OT-I T cells were puri!ed 
and co-cultured with SIINFEKL-pulsed DCs as above, and 
cell conjugates formed after 1 h were !xed and immuno$uo-
rescently labeled. Polarization of the microtubule-organizing 
center (MTOC; identi!ed by tubulin staining) to the T cell–
DC interface was used as a marker of immunological synapse 
formation. Images were obtained by confocal microscopy, 
and the polarization of proteins important for immune syn-
apse formation was scored, with 3 indicating that the protein 
of interest was highly polarized to the T cell/DC interface, 
0 indicating no polarization, and 3 indicating that the protein 
of interest was highly polarized away from the T cell–DC inter-
face. LFA-1 was highly polarized to the immune synapse of 
WT OT-I T cells, whereas Dock8pri/pri OT-I T cells mostly 
showed an even distribution of LFA-1 on the cell surface, in-
dicating a failure of LFA-1 polarization to the synapse (Fig. 6, 
B and C). DOCK8 mutant CD8 T cells also failed to polarize 
actin to the synapse, whereas polarization of PKC-  occurred 
relatively normally (Fig. 6, D–G). Together these results in-
dicate that DOCK8 is required to form a normal T cell im-
mune synapse with antigen-presenting DCs.
DOCK8 is required for persistence of memory CD8 T cells
To extend the aforementioned results and examine how 
DOCK8 mutation a"ects CD8 T cell clonal expansion and 
memory cell persistence in vivo after a viral challenge, OT-I 
T cells with either normal or defective DOCK8, distinguish-
able by CD45.1 and CD45.2 allelic markers, were mixed, and 
1,000 of each were cotransferred into normal C57BL/6 mice. 
survival over this time period (Fig. 5 B, bottom). We con-
clude that the persistence of naive peripheral CD8 T cells is 
intrinsically decreased, albeit modestly, when they lack 
normal DOCK8. Collectively with the aforementioned 
normal thymocyte subsets, the reduced peripheral survival 
provides the simplest explanation for the 50% lower numbers 
of naive CD8 T cells at steady-state.
We asked whether the decrease in survival of naive CD8 
cells lacking normal DOCK8 was caused by a di"erence in 
the expression of the  chain of the receptor for IL-7, 
CD127, or in the T cell response to IL-7. Only a subtle but 
nevertheless consistent decrease in CD127 expression was 
observed on naive CD8 and CD4 T cells from Dock8pri/pri 
mice relative to WT littermates (Fig. S6). DOCK8 mutant 
CD8 and CD4 T cells responded to optimal concentrations 
of IL-7 in culture with indistinguishable short-term survival 
relative to WT controls (Fig. S7 A), although they did ex-
hibit a slight decrease in Bcl-2 induction under these condi-
tions (Fig. S7, B and C).
DOCK8 is required for LFA-1 polarization and rapid 
initiation of cell division
We next examined how DOCK8 de!ciency a"ected CD8 
T cell activation. Naive CD8 T cells speci!c for ovalbumin 
peptide SIINFEKL presented by H2 Kb were puri!ed from 
the spleens of OT-I TCR transgenic mice with WT or mutant 
DOCK8. The T cells were CFSE labeled and co-cultured 
with SIINFEKL-pulsed bone marrow–derived DCs, and 
their cell division was followed over a time course by $ow 
cytometry (Fig. 6 A). After 28 h, most of the WT cells had 
completed their !rst cell division, whereas few mutant cells 
had divided at this time point and only completed their !rst 
division by 34–40 h. Subsequent divisions nevertheless oc-
curred rapidly so that by 49 h there was little di"erence 
Figure 4. Analysis of bone marrow chimeras. Bone 
marrow chimeras were reconstituted with 50% Dock8pri/pri 
CD45.2+ and 50% WT CD45.1+ bone marrow. Controls 
were reconstituted with 50% WT CD45.2 and 50% WT 
CD45.1 bone marrow. (A) Percentage of CD45.2+ cells re-
constituting the cellular subsets shown in these bone mar-
row chimeras. Each bar is the percent reconstitution of a 
cell subset in an individual mouse (indicated by the num-
ber below the bar). Data are representative of two inde-
pendent experiments. DN, double negative; DP, double 
positive. (B) Representative "ow cytometry plots and 
quantitation of CD44 expression on CD45.2+ pri/pri and 
WT (+/+) cells from chimeras as in A. Bars are means, error 
bars indicate SEM, and dots indicate individual mice.
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The DOCK8 mutant T cells clonally expanded almost as 
well as the normal controls in the same animals 7 d after the 
!rst viral challenge, although there was a subtle but consis-
tent decrease in each animal reproduced across many experi-
ments (Fig. 7 B). Thus, the mutant OT-I CD8 T cells 
represented 35% of all donor-derived OT-I CD8 T cells in 
the spleen, peritoneal cavity, and bone marrow at day 7 after 
infection, compared with 45% of the donor cells at the time 
of adoptive transfer (Fig. 7 B, bottom). This result extends 
the aforementioned in vitro proliferation experiments and 
establishes that DOCK8 de!ciency causes only a subtle de-
crease in the net proliferation of CD8 T cells in response to 
viral antigen in vivo.
By 28 d after the !rst viral challenge, when viral antigen 
had been cleared, the OT-I CD8 T cells with WT DOCK8 
had decreased in number in the spleen to 30% relative to 
their peak numbers at day 7 (Fig. 7 B). In contrast, DOCK8 
mutant OT-I T cells in the same animals decreased to 5% of 
their peak number so that they now represented only 10% of 
the overall donor-derived OT-I CD8 T cells (Fig. 7 B, 
bottom). When memory T cells against the virus and the 
SIINFEKL peptide were restimulated by a second viral in-
fection on day 35, both WT and DOCK8 mutant OT-I 
CD8 T cells increased in numbers relative to day 28. Despite 
this, the recall response by the mutant memory T cells was 
less so that they failed to reach the numbers of the !rst expo-
sure and accounted for only 5% of the OT-I CD8 T cells at 
the height of the recall response. The di"erence between the 
normal and DOCK8-defective T cells could not be explained 
by preferential movement of mutant OT-I cells into the bone 
marrow or peritoneum, as comparable di"erences occurred 
in the spleen, bone marrow, and peritoneum (Fig. 7 B). The 
possibility that Dock8pri/pri OT-I T cells were selectively re-
jected because of minor histoincompatibility, either as a 
result of the DOCK8 mutation, other linked mutations, or the 
CD45.1 marker, was ruled out by performing parallel adoptive 
transfers with CD45.1 OT-I control cells that were either 
Dock8pri/+ heterozygous or WT (Fig. 7 C). The persistence 
and recall of both types of control OT-I T cells was equal to 
their cotransferred CD45.1/2 WT cells, whereas again there 
was greatly reduced persistence and recall of CD45.1 OT-I 
T cells that were homozygous for the Dock8 mutation.
Another possible explanation for the failure of DOCK8-
defective CD8 T cells to persist after antigen-induced clonal 
expansion would be that they selectively formed short-lived 
e"ector cells but not cells with the phenotypic markers of 
memory CD8 T cells. To investigate this possibility, we ex-
amined the expression of several markers of CD8 T cell acti-
vation and memory cell formation. Surface expression of 
CD44, CD62L, CD127, and KLRG1 was indistinguishable 
between mutant and WT OT-I cells at all time points (Fig. 8 A), 
indicating that there was no measurable di"erence in the 
proportion of e"ector cells or absence of any phenotypically 
de!ned memory cell subsets to explain the failure of DOCK8 
mutant cells to persist. Slightly lower expression of Bcl2 
and Bim was observed in mutant OT-I cells on day 7 of the 
At the same time, the recipient mice were injected i.p. 
with a modi!ed in$uenza virus that produces the SIINFEKL 
peptide incorporated within the neuraminidase stalk. Thus, 
the transferred OT-I T cells will receive help from, and com-
pete with, normal T cells recognizing other components of 
the virus in the recipient mice so that DOCK8 de!ciency 
will be speci!cally limited to half of the transferred OT-I 
T cells. In addition to testing the cell-autonomous function 
of DOCK8 in CD8 T cells, any mouse to mouse variation in 
viral exposure or kinetics of the response could be internally 
controlled by directly comparing the ratio of the cotrans-
ferred OT-I T cells within a single animal. Primary and sec-
ondary viral challenges of the recipients were performed 
with two separate in$uenza strains, H3N2 (HKx31) and 
H1N1 (PR8), both expressing the SIINFEKL peptide, to re-
call memory CD8 T cell responses against the virus and the 
ovalbumin peptide without interference by neutralizing anti-
bodies against viral envelope proteins (Jenkins et al., 2006).
Flow cytometric analysis of lymphocytes from spleen, 
peritoneal cavity, and bone marrow was used to enumerate 
the transferred mutant and WT OT-I CD8 T cells (Fig. 7 A). 
Both DOCK8 mutant and WT OT-I CD8 T cells in-
creased >1,000-fold in response to viral antigen challenge. 
Figure 5. Survival of naive Dock8pri/pri T cells. WT (CD45.1/CD45.2) 
and Dock8pri/pri (CD45.1) spleen cells were adoptively cotransferred into 
normal C57BL/6 mice (CD45.2). (A) Representative "ow cytometry plots 
showing the percentage of adoptively transferred CD8 T cells at various 
time points after transfer. Numbers indicate the percentage of cells in the 
gate as a percentage of total spleen cells. (B) Quantitation of adoptively 
transferred CD8 T cells in two separate experiments using polyclonal  
T cells (top two panels) and one experiment using OT-I transgenic T cells 
(bottom). Data are representative of two separate experiments for each 
cell type. **, P < 0.01 for 2 test compared with input percentages.
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a single cohort of recipient mice was followed longitudinally 
by measuring the transferred OT-I T cell frequency in their 
blood (Fig. 8 B). As before, there was only a subtle decrease 
in expansion of mutant OT-I T cells 7 d after the !rst viral 
exposure and a much more rapid decline of mutant T cells 
after this !rst antigen was cleared. However, by 195 d, the 
numbers of DOCK8-de!cient OT-I T CD8 cells fell below 
the limit of reliable enumeration in all of the animals ana-
lyzed. In contrast, at the same time point, 
OT-I T cells with normal DOCK8 were 
still readily detected in the blood of three 
of the !ve recipient mice. In these animals, 
a large CD8 T cell recall response was made 
7 d after reexposure to SIINFEKL in$u-
enza (day 202), with the numbers of OT-I 
T cells increasing 100-fold relative to day 
195 immediately before reexposure and 10-
fold relative to the peak of the primary re-
sponse on day 7. Although DOCK8 mutant 
T cells also increased in these animals, they 
comprised <1% of the secondary response. 
Thus, DOCK8 mutation in T cells causes 
only a subtle decrease in the initial virus- 
induced clonal expansion of CD8 T cells in 
vivo but severely compromises the long-
term persistence and recall of their memory 
CD8 progeny.
DISCUSSION
Our !ndings de!ne a qualitative de!cit in 
CD8 T cells caused directly by DOCK8 
de!ciency. Interpreting the consequences 
of DOCK8 mutation in CD8 T cells in 
primary in$uenza response, but this did not reach statistical 
signi!cance in one of two experiments (not depicted).
To de!ne the role of DOCK8 in the persistence and re-
call of memory CD8 T cells over longer time periods, the 
cotransfer of OT-I T cells with normal or defective DOCK8 
was repeated with a 6-mo delay between the primary H3N2 
and secondary H1N1 SIINFEKL in$uenza exposure. To di-
rectly relate the data from primary, memory, and recall phases, 
Figure 6. Dock8pri/pri OT-I T cells show delayed 
proliferation and a defect in immune synapse 
formation in response to antigen presentation. 
(A) Naive WT and pri/pri splenic CD8 T cells were 
labeled with CFSE and cultured with SIINFEKL-
pulsed DCs. Cells were harvested at the indicated 
time points and analyzed for "uorescent intensity 
of CFSE by "ow cytometry. Data are representative 
of !ve independent experiments. (B–G) Naive WT 
and pri/pri splenic CD8 T cells were co-cultured with 
preadhered SIINFEKL-pulsed DCs for 1 h and !xed 
for immuno"uorescence staining. (B, D, and F) Tubu-
lin (red) staining was used to mark recruitment of 
the MTOC to the immune synapse along with 
costaining for the protein of interest (green). Images 
are representative of three independent experiments. 
Bars, 10 µm. (C, E, and G) Scoring of LFA-1 (+/+,  
n = 168; pri/pri, n = 176), actin (+/+, n = 70; pri/pri,  
n = 77), and PKC-  (+/+, n = 50; pri/pri, n = 46) 
recruitment to the interface between the T cell  
and DC (marked by asterisks). Bars are mean, and 
error bars indicate SD. Scoring was performed blind 
as per Materials and methods. Statistical analysis was 
performed by the Student’s t test.
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Our analysis has identi!ed an important confounding fac-
tor, namely that many of the circulating CD8 T cells corre-
spond to a CD45RA+CCR7  exhausted TEMRA cell subset 
that is poorly responsive even in normal individuals. Further-
more, many of the CD45RA  memory CD8+ T cells in 
these patients exhibited phenotypic and functional features 
of such exhausted cells. This phenotype is likely to re$ect 
the repeated viral exposure faced by these patients, as has 
been observed in patients with other chronic infections such 
as late stage HIV (Chen et al., 2001; Brenchley et al., 2003) 
and patients with EBV-positive X-linked lymphoprolifera-
tive disease (Plunkett et al., 2005). We also found that 
DOCK8 de!ciency in human T cells abrogated the robust 
DOCK8-de!cient humans is complicated by their humoral 
immunode!ciency, varying degrees of lymphopenia, con-
current infections, and antibiotic and antiviral medication. 
Figure 7. Pairwise analysis of persistence of Dock8pri/pri CD8 T cells 
after viral challenge. OT-I (V 2+) T cells with either WT or mutant 
DOCK8 were mixed in a de!ned ratio and cotransferred into C57BL/6 
mice, which were then injected i.p. with modi!ed in"uenza virus (!rst 
HKx31-SIINFEKL and then PR8-SIINFEKL), as indicated by the black  
arrows. (A) Representative "ow cytometry plots showing identi!cation of 
transferred cells at various time points. Control indicates no adoptive 
transfer. (B) Time course of adoptive transfer and infection. Graphs show 
numbers of transferred WT (open) and Dock8pri/pri (closed) cells at various 
time points within the same recipient mouse (top) and percentage contri-
bution of mutant cells to total donor cells within spleen (open), perito-
neum (closed), and bone marrow (striped; bottom). For the bottom panel, 
bars are means, and error bars indicate SEM. Data are representative of 
two independent experiments. (C) Adoptive transfers as in A and B with 
three experimental groups. Recipients were injected with Dock8pri/pri and 
WT (+/+) cells, Dock8pri/+ and WT (+/+) cells, or WT combined with WT 
cells. Graphs show numbers of transferred WT (open) and either Dock8pri/pri 
(left), Dock8pri/+ (middle), or WT (right panel; all closed) cells at various 
time points in the same recipient mouse.
Figure 8. Further investigation of the consequences of DOCK8 
de!ciency for persistence and recall of primed OT-I CD8 T cells. OT-I 
T cells with either WT or mutant DOCK8 were mixed in a de!ned ratio and 
cotransferred into C57BL/6 mice, which were then injected i.p. with modi-
!ed in"uenza virus, as indicated by the black arrows. (A) Overlay histo-
grams of the expression of surface markers on WT (black) and Dock8pri/pri 
(red) donor and recipient (gray) CD8 T cells at the indicated time points 
after adoptive transfer. (B) Longitudinal time course of adoptive transfer 
and infection. Graphs show percentages of transferred WT (blue) and 
Dock8pri/pri (red) OT-I CD8 T cells in blood at various time points within the 
same recipient mouse (denoted by different symbols; top) and percent 
contribution of mutant cells to total donor cells at various time points 
after adoptive transfer (bottom). Bars are medians, and dots indicate indi-
vidual mice. Results of one independent experiment are shown.
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OT-I T cells exhibited a persistence defect (70% decline in 
contribution to transferred OT-I cells over 21 d between 
days 7 and 28; Figs. 7 B and 8 B) that appears more severe 
than the survival defect exhibited by unstimulated OT-I cells 
bearing the mutation (50% decline in contribution to trans-
ferred OT-I cells over 39 d; Fig. 5 B). A subtle decrease in 
CD127 expression and IL-7–induced Bcl-2 was observed in 
DOCK8 mutant naive T cells and could theoretically explain 
the subtle decrease in their survival in vivo, but future studies 
will be needed to address how DOCK8 de!ciency a"ects 
this pathway. The more dramatic decrease in memory CD8 
T cell survival was not accompanied by any measurable de-
crease in CD127 expression, and only a marginal decrease in 
Bcl-2. Elucidating the molecular pathway by which DOCK8 
promotes survival of naive and memory CD8 T cells and how 
this may relate to the synapse defect will be challenging given 
the many gaps in current understanding of the signals that in-
duce long-lived memory T cells. Regardless of its molecular 
basis, this intrinsic defect in naive and memory T cell persis-
tence coupled with uncontrolled viral infections provides an 
explanation for the markedly decreased frequency of circu-
lating naive CD8 T cells and the dramatic shift to CD8+ 
CD45RA+CCR7  TEMRA cells in DOCK8-de!cient patients.
Although the experiments here establish that DOCK8 
de!ciency causes a striking qualitative de!cit in CD8 T cells, 
it is unlikely that the CD8 T cell defect alone accounts for the 
peculiar spectrum of viral infections and tissue-tropism seen in 
DOCK8 de!ciency. Bone marrow transplantation resolved 
the cutaneous viral infections in two DOCK8-de!cient pa-
tients, indicating that hematopoietic rather than epidermal 
defects are responsible (Bittner et al., 2010; Gatz et al., 2011). 
De!ciency of the skin-homing subset of CD8 T cells is un-
likely to explain the cutaneous infections because we !nd 
normal frequencies of skin-homing CD103+ CD8 T cells in 
the skin and gut of DOCK8 mutant mice (unpublished data), 
as well as in the circulation of DOCK8-de!cient patients 
(unpublished data). It is signi!cant that cutaneous infections 
with HSV, HPV, and M. contagiosum are much less prevalent 
in severe combined immunode!ciency or selective CD8 
T cell de!ciency, indicating that the CD8 T cell defects de-
!ned here are unlikely to be su%cient to explain the preva-
lence of these viral infections in DOCK8 de!ciency (La"ort 
et al., 2004; Cerundolo and de la Salle, 2006; Notarangelo 
et al., 2009). Uncontrolled cutaneous infections with many 
of the same viruses are associated with evidence for greatly 
exaggerated Th2 cell activity in otherwise normal individuals 
with atopic dermatitis, asthma, and food allergy (Wollenberg 
et al., 2003; Beck et al., 2009). In this setting, Th2 cytokines 
are believed to suppress Th1 cells and IFN-  production in 
the skin, thereby reducing control of these cutaneous viral 
infections by CD8 T cells and NK cells. Thus, it is attractive 
to speculate that in AR-HIES caused by DOCK8 de!ciency, 
the e"ects of excessive Th2 cells interact with the qualitative 
defect in CD8 T cells to produce the severe HSV, M. conta-
giosum, and other skin viral infections. In contrast, autosomal 
dominant HIES (AD-HIES) caused by STAT3 mutations 
proliferative response observed for normal CD4 and CD8 
T cells after stimulation through the TCR and co-stimulatory 
molecules. This most likely re$ects the advanced level of 
activation of these cells in vivo as a result of chronic pathogen 
exposure, which can cause extensive proliferation resulting 
in replicative senescence (Brenchley et al., 2003; Papagno 
et al., 2004). Indeed, a study of human CD8+ T cell subsets 
found that expression of CD57 correlates with impaired pro-
liferation and increased susceptibility to apoptosis in vitro 
(Brenchley et al., 2003). Similarly, CD8+ T cells that are 
CD57+ (Brenchley et al., 2003), CD57+CCR7 CD27   
(Papagno et al., 2004), or CD45RA+CCR7 CD27 CD28  
(Rufer et al., 2003; Romero et al., 2007) have undergone the 
greatest levels of expansion in vivo, as determined by quanti-
tation of TCR excision circles or telomere lengths, yet fail to 
proliferate in vitro in response to TCR-mediated stimulation. 
Furthermore, exogenous cytokines failed to restore the pro-
liferative defect of CD57+CD8+ human T cells (Brenchley 
et al., 2003). Thus, the defects in proliferation of all DOCK8-
de!cient CD8+ T cell subsets is consistent with an enrich-
ment in the frequency of CD57+CD27 CD28  cells within 
both the memory and TEMRA cell subsets, as well as unusually 
high expression of CD95 by naive cells.
When DOCK8 de!ciency was con!ned to a subset of the 
CD8 T cell repertoire in speci!c pathogen-free mice, we 
were able to establish an essential, intrinsic role for DOCK8 
in CD8 T cells that has its most dramatic e"ects on the per-
sistence and recall of antigen-stimulated memory CD8 
T cells. These e"ects, together with the e"ects of DOCK8 
de!ciency on LFA-1 polarization at the CD8 T cell synapse 
and on initial entry into cell division, extend and translate to 
human immunity a growing body of evidence that normal CD8 
T cell memory depends on the quality of stimuli received 
through the T cell synapse before the !rst cell division.
DOCK8 was found not to be essential for thymic pro-
duction of T cells, with normal numbers of single-positive 
CD8 and CD4 cells, no evidence for a defect in CD8 cell–
positive selection in OT-I transgenic mice, and modest com-
petitive decreases in all thymic subsets in 50:50 chimeras. 
Although we have not directly measured thymic egress, there 
was no consistent evidence for either accumulation or de!-
ciency of mature CD69 CD62L+ single-positive T cells in 
the thymus as occurs in animals with thymic egress defects 
(Matloubian et al., 2004; Carlson et al., 2006; Shiow et al., 
2008). DOCK8 played a greater role in peripheral CD8 
T cells, with mutation of DOCK8 decreasing the number 
of naive T cells by 50%. The numbers of activated/memory 
CD44hi CD8 T cells were nevertheless slightly increased, 
presumably because these were sustained by antigen-driven 
or homeostatic proliferation (Surh and Sprent, 2008). In 
competitive bone marrow chimeras, 95% of the peripheral 
CD8 T cells were derived from the normal rather than the 
mutant bone marrow, and there was no relative shift toward 
CD44hi T cells among the DOCK8 mutant T cells. Cell trans-
fers show that DOCK8-de!cient naive CD8 T cells persist less 
well in peripheral lymphoid tissues and that in$uenza-activated 
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resemble DOCK8-de!cient OT-I cells more closely (Teixeiro 
et al., 2009). The TCR-  mutation selectively interfered 
with clustering of the TCR and PKC-  at the T cell synapse 
with antigen-presenting cells and the activation of NF- B. 
When the TCR-  mutant OT-I T cells were adoptively 
transferred into mice infected with Listeria monocytogenes ex-
pressing ovalbumin antigen, the primary clonal expansion 
was comparable with normal OT-I T cells, but the mutant 
T cells subsequently declined more rapidly and made little 
recall expansion upon a second challenge (Teixeiro et al., 
2009). The behavior of Dock8pri/pri OT-I T cells most closely 
resembles normal CD8 OT-I T cells stimulated by ICAM-
1–de!cient DCs (Scholer et al., 2008). Using normal and 
Icam1 /  mice, Scholer et al. (2008) adoptively transferred 
normal OT-I T cells and then immunized them with anti-
DEC205 mAb coupled to ovalbumin with or without an-
tagonistic anti-CD40 mAb. Upon immunization, the primary 
clonal expansion of OT-I T cells was comparable in the two 
groups, but during the contraction phase, most of the OT-I 
T cells were lost in the Icam1 /  mice, and little recall clonal 
expansion occurred upon rechallenge. Two-photon micros-
copy revealed a failure to form long-lived contacts between 
T cells and Icam1 /  DCs, consistent with other evidence 
that prolonged contact with antigen is important for the for-
mation of CD8 memory T cells (Bachmann et al., 2006). 
Based on the !ndings here and studies of other DOCK pro-
teins (Côté and Vuori, 2007), DOCK8 de!ciency in OT-I 
T cells may interfere with the inside-out signals needed to 
activate LFA-1 binding to ICAM-1 on DCs and to promote 
actin !laments that polarize LFA-1/ICAM-1 at the synapse.
The similarities between the e"ects of DOCK8 de!-
ciency, ICAM-1 de!ciency, and TCR-  mutation provide 
three independent lines of experimental evidence connecting 
the quality of the TCR synapse and the intracellular signals it 
generates with the persistence of memory CD8 T cells. Given 
the delay to !rst cell division caused by DOCK8 de!ciency 
in mice and the impaired proliferation of T cells from 
DOCK8-de!cient patients, it is conceivable that qualitative 
di"erences in TCR signals are imprinted or stored in the 
T cell during the period leading up to the !rst cell division 
and then passed on silently through the rapid successive divi-
sions to become apparent only when the cells exit cycle and 
need to persist as nondividing memory cells (Mercado et al., 
2000; Kaech and Ahmed, 2001; van Stipdonk et al., 2001). 
Further analysis of DOCK8 de!ciency in man and mouse 
will help to establish general principles for persistence of CD8 
T cell–mediated immunity, to guide new strategies for en-
hancing this arm of immunity in chronic viral diseases and can-
cer and for suppressing CD8 T cell memory in transplantation.
MATERIALS AND METHODS
Mice. Mice were housed in speci!c pathogen-free conditions, and all ex-
periments were approved by the Australian National University Animal 
Ethics and Experimentation Committee. Dock8pri/pri mice were generated as 
previously described (Randall et al., 2009). C57BL/6 and C57BL/6.SJL-
CD45.1 mice were obtained from Australian National University Bioscience 
Services. OT-I mice on the C57BL/6 background (Hogquist et al., 1994) 
results in mucocutaneous infections with Candida albicans 
and cutaneous infection with Staphylococcus aureus rather 
than uncontrolled viral infections. AD-HIES is associated with 
defective Th17 cells (de Beaucoudrey et al., 2008; Ma et al., 
2008; Milner et al., 2008; Renner et al., 2008) and perhaps 
other cell or cytokine defects, which result in this speci!c 
infectious susceptibility.
Patients with another primary immunode!ciency that 
causes qualitative T cell abnormalities, Wiskott–Aldrich 
syndrome (WAS), share some clinical characteristics with 
DOCK8 immunode!ciency patients in that they have ec-
zema, a similar range of infections with M. contagiosum and 
papilloma and herpes viruses (Atherton et al., 2004), and ele-
vated levels of IgE (Bosticardo et al., 2009). The WAS pro-
tein is important for T cell synapse formation (Dupré et al., 
2002; Badour et al., 2003; Cannon and Burkhardt, 2004), 
and its expression in DCs is important for interactions be-
tween naive CD8 T cells and DCs (Pulecio et al., 2008). It 
had been previously assumed that the cutaneous infections 
in WAS were secondary to the eczema (Bosticardo et al., 2009), 
but the similarities between the clinical manifestations and 
cellular consequences of WAS protein and DOCK8 de!-
ciency support a link between susceptibility to these viral 
infections and the presence of a qualitative CD8 T cell syn-
apse defect. A similar spectrum of viral infections (papilloma-
virus and M. contagiosum) is also seen in epidermodysplasia 
verruciformis (Casanova and Abel, 2007). This primary 
immunode!ciency occurs because of mutations in EVER1 
and EVER2 (Ramoz et al., 2002), disrupting zinc transport 
in keratinocytes, with increased zinc concentrations in the 
nucleus aiding papillomavirus replication (Lazarczyk et al., 2008). 
However, the molecular mechanism underlying suscepti-
bility to a similar spectrum of infections in DOCK8 de!-
ciency and EVER-1/2 de!ciency is distinct because DOCK8 
patients do not have intrinsic abnormalities of their keratino-
cytes as bone marrow transplantation has been associated 
with resolution of chronic viral infections (Bittner et al., 
2010; Gatz et al., 2011).
Although the initial clonal expansion of DOCK8-de!cient 
OT-I CD8 T cells in response to in$uenza-produced antigen 
was almost equal to their paired OT-I WT T cells, the per-
sistence of mutant CD8 T cells after antigen was cleared was 
greatly diminished, and they exhibited poor secondary ex-
pansion upon reexposure to a CD8 T cell cross-reacting in-
$uenza strain. The preferential e"ect of DOCK8 mutation 
on the persistence and recall of CD8 memory T cells has 
parallels with several other studies (Williams et al., 2006b; 
Scholer et al., 2008; Teixeiro et al., 2009). Like DOCK8-
de!cient CD8 T cells, IL-2Ra–de!cient CD8 T cells also 
show normal primary expansion upon viral challenge in vivo 
but are greatly decreased in their secondary clonal expansion 
upon reexposure to antigen (Williams et al., 2006b). How-
ever, Il2ra de!ciency di"ers because it does not accelerate 
the loss of antigen-speci!c CD8 T cells during the contrac-
tion phase after the primary response. OT-I T cells bear-
ing a mutation in the TCR -chain transmembrane domain 
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of 2 & 104 CFSE-labeled T cells/well. Cells were harvested at the indicated 
time points.
Immuno!uorescence and confocal microscopy. For immuno$uores-
cence staining, 2 & 104 naive splenic WT and pri/pri OT-I T cells/well were 
co-cultured with 3 & 104 SIINFEKL-pulsed bone marrow–derived DCs/
well in chamber slides (Oliaro et al., 2010). The cell conjugates formed were 
!xed at 1 h after incubation with !xative solution (100 mM Pipes, 5 mM 
MgSO4, 10 mM EGTA, 2 mM DTT, and 3.7% [wt/vol] paraformaldehyde, 
pH 7.0) for 10 min. The cells were then washed twice and incubated in per-
meabilization solution (PBS, 0.1% Triton X-100, and 0.5% BSA [wt/vol]) 
for 5 min before being washed and kept in blocking agent (PBS and 1% BSA 
[wt/vol]) overnight at 4°C. Primary antibodies against the proteins of inter-
est (anti–LFA-1 [BD], anti–PKC-  [Santa Cruz Biotechnology, Inc.], and 
rhodamine-conjugated actin/phalloidin [Invitrogen]), together with mouse 
-tubulin (Rocklands) or rabbit -tubulin (Sigma-Aldrich), were added and 
incubated for 45 min at 4°C in the dark. Secondary antibodies (anti–rat and 
anti–rabbit Alexa Fluor 488 and anti–mouse and anti–rabbit Alexa Fluor 
546) were added after washing and incubated for another 45 min at 4°C in 
the dark. The cells were then washed and mounted in ProLong Gold anti-
fade reagent with DAPI (Invitrogen). Cells were imaged using a confocal 
microscope (Fluoview FV1000; Olympus) equipped with a 12.9-mW 488-nm 
multi-ion argon laser, a 1-mW 543-nm multi-ion green HeNe laser, and an 
11-mW 633-nm red HeNe laser. All images were captured using a Plan-
ApoN 60& oil immersion objective (NA = 1.42). The images were subse-
quently processed using the Olympus Micro FV10-ASW program and 
displayed as z-stack projections (sections = 0.5 µm). To acquire images in 
which an immune synapse was formed, conjugates with the MTOC (as 
marked by -tubulin) of T cells polarized to the interface with the DCs were 
chosen. Blinded scoring of the images was used as a means for quantifying 
the localization of proteins of interest. An integer score was given from 
3 (very polarized to the DC–T cell interface), to 0 (not polarized), to 3 
(very polarized away from the interface).
Chromium release killing assay. Splenocytes from C57BL/6 mice were 
pulsed with 1 µM SIINFEKL peptide for 2 h at room temperature before ir-
radiation at 6 Gy for 30 min. Splenocytes from WT or pri/pri OT-I mice 
were added to the irradiated C57BL/6 splenocytes with the addition of 
50 U/ml IL-2 and cultured for 5 d. DCs labeled with 100 µCi Cr51 were pulsed 
with SIINFEKL peptide for 1 h at 37°C. Activated WT and pri/pri OT-I 
splenocytes were added to the DCs at the indicated ratios and incubated at 
37°C for 4 h. Supernatant was collected and analyzed for chromium release 
by an automatic gamma counter (Wallac Wizard 1470; PerkinElmer).
T cell stimulation. Spleen cells from control and mutant mice were iso-
lated, red cells were lysed, and the cells were counted by trypan blue exclu-
sion. Three million cells (per milliliter in a 24-well plate) from each animal 
were cultured in the presence or absence of 25 ng/ml IL-7 (R&D Systems) 
with the complete tissue culture medium at 37°C and 5% CO2 for the indi-
cated time points. Cells were stained as in Flow cytometry of murine cells.
Human samples. Peripheral blood was collected from normal healthy do-
nors (Australian Red Cross Blood Service) and DOCK8-de!cient patients 
(Table I). All human experiments were approved by the Sydney South West 
Area Health Service and St. Vincent’s Hospital Darlinghurst Human Re-
search Ethics Committees, as well as by the institutional review boards of the 
Necker Medical School, the Rockefeller University, and the National Insti-
tute of Allergy and Infectious Diseases (National Institutes of Health). For 
analysis, the following mAbs were used: FITC-conjugated anti–human 
CCR7 (150503; R&D systems), PerCP-Cy5.5–conjugated anti–human 
CD45RA (HI100; eBioscience), PE-Cy7–conjugated anti-CD4 (SK3; BD), 
Paci!c blue–conjugated anti–human CD8 (RPA-T8; BD), eFluor450- 
conjugated anti–human CD127 (eBioRDR5; eBioscience), PE-conjugated 
anti–human CD244 (2B4; Beckman Coulter, c1.7), PE-conjugated anti– 
human CD57 (HCD57; BioLegend), APC-human–conjugated anti-CX3CR1 
were provided by F. Carbone (The University of Melbourne, Parkville, Vic-
toria, Australia) and were crossed with Dock8pri/pri or Dock8+/+ B6.CD45.1 
mice to obtain OT-I transgenic o"spring that were either Dock8pri/pri CD45.1 
homozygous or Dock8+/+ CD45.1/CD45.2 heterozygous.
Procedures. Bone marrow chimeras were generated as previously described 
(Randall et al., 2009). For adoptive transfers, C57BL/6 recipient mice were 
injected intravenously with 103 FACS-sorted OT-I CD8 T cells (50:50 mix-
ture of Dock8pri/pri CD45.1 homozygous and Dock8+/+ CD45.1/2 hetero-
zygous CD8 T cells). For in$uenza challenge experiments, the mice were 
also injected i.p. with H3N2 (A/HKx31) followed later by H1N1 (A/PR8) 
strains of recombinant in$uenza A viruses expressing SIINFEKL OVA257- 
264 (Jenkins et al., 2006) obtained from S. Turner (The University 
of Melbourne).
Flow cytometry of murine cells. Single cell suspensions of spleen, LN, 
and bone marrow were obtained as described previously (Randall et al., 
2009). Data were acquired on a FACSCalibur (BD), FACS Sort (BD), or 
LSRII (BD) $ow cytometer and analyzed using FlowJo software (Tree Star). 
The following antibodies were used for surface staining of lymphocytes for 
$ow cytometry (from BD unless otherwise stated; clones indicated): FITC-
conjugated anti-CD4 (GK1.5), peridinin chlorophyll protein (PerCP)–cyanine 
(Cy) 5.5–conjugated anti-CD4 (RM4.5), PE-indotricarbocyanine (PE-Cy7)–
conjugated anti-CD4 (RM 4.5), allophycocyanin (APC)-conjugated anti-
CD4 (RM 4.5), APC-Cy7–conjugated anti-CD4 (GK1.5; BioLegend), 
PE-conjugated anti-CD4 (GK1.5), PE-conjugated anti-CD8a (53–6.7), 
PerCPCy5.5-conjuated anti-CD8a (53-6.7), Alexa Fluor 405–conjugated 
anti-CD8a (5H10; Invitrogen), APC–Alexa Fluor 750–conjugated anti-
CD8a (53-6.7, 5H10), PE-Cy7–conjugated anti-CD8a (53-6.7; BioLegend), 
APC-conjugated anti-CD25 (PC61), APC-Cy7–conjugated anti-CD25 
(PC61; BioLegend), PE-conjugated anti-CD27 (LG.3A10), APC-conjugated 
anti-CD44 (1M7), Alexa Fluor 405–conjugated anti-CD44 (1M7; 
Invitrogen), Paci!c blue–conjugated anti-CD44 (IM7; BioLegend), PE-
conjugated anti-CD45.1 (A20), Alexa Fluor 700–conjugated anti-CD45.1 
(A20; BioLegend), Paci!c blue–conjugated anti-CD45.2 (104; BioLegend), 
FITC-conjugated anti-CD45.2 (104), APC-conjugated anti-CD45.2 (104; 
eBioscience), FITC-conjugated anti-CD62L (MEL-14), APC-Cy7–conjugated 
anti-CD62L (MEL-4; BioLegend), PerCPCy5.5-conjugated anti-CD69 
(H1.2F3), FITC-conjugated anti-CD122 (5H4), PE-indodicarbocyanine 
(PE-Cy5)–conjugated anti-CD127 (A7R34; eBioscience), PE-conjugated 
anti-CD152 (UC10-4F10-11), FITC-conjugated anti-B220 (RA3-6B2), 
APC–Alexa Fluor 750–conjugated anti-B220 (RA3-6B2; Invitrogen), 
APC-conjugated anti-KLRG1 (2F1; eBioscience), PE-conjugated anti-
TCR V 2 (B20.1), FITC-conjugated anti-CD45RB (16A), PE-conjugated 
anti-PD-1 (J43), and Alexa Fluor 700–conjugated CD3 (17A2; eBioscience). 
Cell viability was determined with 7 aminoactinomycin D (Invitrogen) and 
FITC-conjugated anti–Annexin V. When staining using Annexin V, 
Annexin V binding bu"er (BD) was used. For FACS sorting, splenocytes were 
stained with PE-conjugated anti-CD4 and FITC-conjugated anti-B220 as 
described above, and the negatively selected populations were harvested 
for the adoptive cell transfers. The following antibodies were used for 
intracytoplasmic staining of lymphocytes: PerCP-conjugated anti-tbet 
(eBio4B10; eBioscience), FITC-conjugated Bcl-2 (3F11), and Dylight-
conjugated anti-Blimp (3H2-E8). Anti-Bim (clone 3C5; a gift from 
A. Strasser, Walter and Eliza Hall Institute of Medical Research, Parkville, 
Victoria, Australia) was conjugated to Alexa Fluor 647 using a Protein 
Labeling kit (A20173; Invitrogen).
CFSE proliferation. Splenic WT and pri/pri OT-I T cells were isolated 
using a MACS column negative selection kit (Miltenyi Biotech) according 
to the manufacturer’s protocol. Naive CD8 T cells were labeled with a !nal 
concentration of 5 µM CFSE as per Quah et al. (2007). Bone marrow–
derived DCs were derived as described previously (Oliaro et al., 2010) and 
seeded into 8-well chamber slides at 3 & 104 cells/well. They were then 
pulsed with SIINFEKL peptide for 1 h and washed twice before the addition 
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(2A9-1; BioLegend), APC-conjugated anti–human CD27 (O323; eBiosci-
ence), PE-conjugated anti–human CD95 (DX2; BD), APC-conjugated 
anti–human CD11a (HI111; BD), PE-conjugated anti–human CD11b 
(D12; BD), APC-conjugated anti–human CD28 (CD28.2; BioLegend), PE-
conjugated anti–human perforin (dG9; eBioscience), and APC-conjugated 
anti–human Granzyme B (GB11; Invitrogen). CD4 and CD8 T cells were 
isolated from freeze thawed PBMCs using Dynal beads (Invitrogen) as per 
the manufacturer’s instructions. CD4+ T cells were labeled with anti-CCR7 
and anti-CD45RA mAbs and then sorted into naive and memory popula-
tions using a FACSAria (BD). Naive and memory CD4 T cells were isolated 
as CD45RA+CCR7+ and CD45RA CCR7+/  cells, respectively, whereas 
naive and di"erent central and e"ector memory CD8 T cells were isolated 
by sorting CD45RA+CCR7+, CD45RA CCR7 /+, and CD45RA+CCR7  
cells. CD4 and CD8 naive and memory T cell subsets were labeled with CFSE 
and cultured with TAE beads (one bead for every two cells; Miltenyi Bio-
tech) with or without 20 U/ml recombinant human IL-2 (Millipore) for 5 d. 
After this time, proliferation was determined by measuring CFSE dilution.
Data analysis and statistics. Statistical analyses were performed using 
Prism software (GraphPad Software) or Excel (Microsoft). Statistical com-
parison was performed with unpaired Student’s t tests and 2 analysis as noted 
in the text.
Online supplemental material. Fig. S1 shows extended phenotypic analy-
sis of human DOCK8-de!cient CD8+ T cells. Fig. S2 shows T cell counts 
in blood and LNs for Dock8pri/pri and C57BL/6. Fig. S3 shows that there is no 
evidence of an exhausted CD8 T cell phenotype in Dock8pri/pri and Dock8cpm/cpm 
mice. Fig. S4 compares T cell numbers in Dock8pri/pri, Dock8cpm/cpm, and C57BL/6 
mice. Fig. S5 shows further analysis of thymic subsets in Dock8pri/pri mice. 
Fig. S6 quanti!es CD127 on the surface of T cell subsets from Dock8pri/pri and 
C57BL/6 mice. Fig. S7 shows survival of Dock8pri/pri and C57BL/6 T cells 
in culture with and without the addition of IL-7. Fig. S8 shows a chromium 
release assay using Dock8pri/pri OT-I T cells. Online supplemental material is 
available at http://www.jem.org/cgi/content/full/jem.20110345/DC1.
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